JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB93741

Anti-Cytokeratin 18 antibody [SP69]

  • BOND RX™ Validated
  • 20ul selling size
  • RabMAb
  • Advanced Validation
  • Recombinant
  • What is this?

Be the first to review this product! Submit a review

|

(9 Publications)

Rabbit Recombinant Monoclonal Cytokeratin 18 antibody. Suitable for mIHC, IHC-P, Flow Cyt (Intra), WB, ICC/IF and reacts with Human samples. Cited in 9 publications.

View Alternative Names

CYK18, PIG46, KRT18, Cell proliferation-inducing gene 46 protein, Cytokeratin-18, Keratin-18, CK-18, K18

11 Images
Multiplex immunohistochemistry - Anti-Cytokeratin 18 antibody [SP69] (AB93741)
  • mIHC

Lab

Multiplex immunohistochemistry - Anti-Cytokeratin 18 antibody [SP69] (AB93741)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human breast labelling Cytokeratin 18 with ab93741 at 1/200 dilution (1.02 µg/mL) (B), Collagen VI with ab271938 at 1/500 dilution (2.084 μg/ml) (C) and Cytokeratin 14 with ab236439 at 1/2000 dilution ( 0.519 μg/ml) (D). Opal Polymer HRP Ms + Rb was used as a secondary antibody, and DAPI was used for a nuclear counter stain. Heat mediated antigen retrieval with Citrate buffer (pH 6.0, epitope retrieval solution 1) for 20 mins. Panel A : merged staining of anti-Cytokeratin 14 (magenta; Opal™690), anti-Cytokeratin 18 (green; Opal™520) and anti-Collagen VI (red; Opal™570) on human breast. Panel B : anti-Cytokeratin 18 stained on luminal epithelial cells. Panel C : anti-Collagen VI stained on stroma. Panel D : anti-Cytokeratin 14 stained on myoepithelial cells. The section was incubated in three rounds of staining : in the order of ab236439 for 30 mins, ab93741 for 10 mins, and ab271938 for 30 mins at room temperature. Each round was followed by a separate fluorescent tyramide signal amplification system. The immunostaining was performed on a Leica Biosystems BOND® RX instrument with an Opal™ 4-color kit. Image acquisition was performed with Leica SP8 confocal microscope.

Flow Cytometry (Intracellular) - Anti-Cytokeratin 18 antibody [SP69] (AB93741)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-Cytokeratin 18 antibody [SP69] (AB93741)

Flow cytometric analysis of rabbit anti-Cytokeratin 18 (SP69) antibody ab93741(1/100) in HeLa cells (green) compared to negative control of rabbit IgG (blue).

Flow Cytometry (Intracellular) - Anti-Cytokeratin 18 antibody [SP69] (AB93741)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-Cytokeratin 18 antibody [SP69] (AB93741)

Flow Cytometry analysis of HeLa (human cervix adenocarcinoma epithelial cell) cells labeling Cytokeratin 18 with purified ab93741 at 1 : 240 dilution (1.00 µg/ml) Red. Cells were fixed with 4% paraformaldehyde . A Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) secondary antibody was used at 1 : 2000 dilution. Isotype control - Rabbit monoclonal IgG (ab172730) / Black. Unlabeled control - Unlabelled cells / Blue.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytokeratin 18 antibody [SP69] (AB93741)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytokeratin 18 antibody [SP69] (AB93741)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human endometrium tissue sections labeling Cytokeratin 18 with ab93741 at 1/200 dilution (1.21 µg/ml). Heat mediated antigen retrieval was performed Heat mediated antigen retrieval with sodium citrate buffer (pH 6.0, epitope retrieval solution 1) for 10 mins. Rabbit specific IHC polymer detection kit HRP/DAB (ab209101) was used as the secondary antibody. Negative control : PBS instead of the primary antibody. Hematoxylin was used as a counterstain.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytokeratin 18 antibody [SP69] (AB93741)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytokeratin 18 antibody [SP69] (AB93741)

Immunihistochemical staining of human stomach with ab93741.

Immunocytochemistry/ Immunofluorescence - Anti-Cytokeratin 18 antibody [SP69] (AB93741)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-Cytokeratin 18 antibody [SP69] (AB93741)

ICC/IF image of ab93741 stained HCT116 cells. The cells were 4% formaldehyde fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody ab93741 at 1/500 dilution overnight at +4°C. The secondary antibody (green) was DyLight® 488 Goat anti-Rabbit IgG (H+L) used at a 1/250 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43μM.

Immunocytochemistry/ Immunofluorescence - Anti-Cytokeratin 18 antibody [SP69] (AB93741)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-Cytokeratin 18 antibody [SP69] (AB93741)

Immunocytochemistry/ Immunofluorescence analysis of HeLa (human cervix adenocarcinoma epithelial cell) cells labeling Cytokeratin 18 with purified ab93741 at 1 : 100(2.4 µg/ml). Cells were fixed in 4% paraformaldehyde and permeabilized with 0.1% Triton X-100. Cells were counterstained with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) 1 : 200 (2.5 µg/ml). Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) was used as the secondary antibody at 1 : 1000 (2 µg/ml) dilution. DAPI nuclear counterstain. PBS instead of the primary antibody was used as the secondary antibody only control.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytokeratin 18 antibody [SP69] (AB93741)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytokeratin 18 antibody [SP69] (AB93741)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human stomach tissue sections labeling Cytokeratin 18 with ab93741 at 1/200 dilution (1.21 µg/ml). Heat mediated antigen retrieval was performed Heat mediated antigen retrieval with sodium citrate buffer (pH 6.0, epitope retrieval solution 1) for 10 mins. Rabbit specific IHC polymer detection kit HRP/DAB (ab209101) was used as the secondary antibody. Negative control : PBS instead of the primary antibody. Hematoxylin was used as a counterstain.

Flow Cytometry (Intracellular) - Anti-Cytokeratin 18 antibody [SP69] (AB93741)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-Cytokeratin 18 antibody [SP69] (AB93741)

Overlay histogram showing MCF7 cells stained with ab93741 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab93741, 1/1000 dilution) for 30 min at 22°C. The secondary antibody used was Alexa Fluor® 488 goat anti-rabbit IgG (H&L) (ab150077) at 1/2000 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit IgG (monoclonal) (0.1μg/1x106 cells) used under the same conditions. Unlabelled sample (blue line) was also used as a control. Acquisition of >5,000 events were collected using a 20mW Argon ion laser (488nm) and 525/30 bandpass filter. This antibody gave a positive signal in MCF7 cells fixed with 4% paraformaldehyde (10 min)/permeabilized with 0.1% PBS-Tween for 20 min used under the same conditions.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytokeratin 18 antibody [SP69] (AB93741)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytokeratin 18 antibody [SP69] (AB93741)

ab93741 at 1/200 dilution staining Cytokeratin 18 in formalin-fixed, paraffin-embedded Human breast carcinoma tissue.

Western blot - Anti-Cytokeratin 18 antibody [SP69] (AB93741)
  • WB

Unknown

Western blot - Anti-Cytokeratin 18 antibody [SP69] (AB93741)

All lanes:

Western blot - Anti-Cytokeratin 18 antibody [SP69] (ab93741) at 1/25 dilution

All lanes:

A431 cell lysate

Predicted band size: 48 kDa

Observed band size: 52 kDa

false

  • Biotin

    Biotin Anti-Cytokeratin 18 antibody [SP69]

  • Carrier free

    Anti-Cytokeratin 18 antibody [SP69] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

SP69

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

ICC/IF, IHC-P, WB, Flow Cyt (Intra), mIHC

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "mIHC" : {"fullname" : "Multiplex immunohistochemistry", "shortname":"mIHC"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "mIHC-species-checked": "testedAndGuaranteed", "mIHC-species-dilution-info": "", "mIHC-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/200", "IHCP-species-notes": "<p>Incubate for 30 minutes at RT. Perform heat mediated antigen retrieval before commencing with IHC staining protocol by boiling tissue sections in 10mM citrate buffer, pH 6.0 for 10 min followed by cooling at RT for 20 min.</p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/2000", "FlowCytIntra-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/200", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/1000", "ICCIF-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A/G
Purification notes
Purified from TCS by protein A/G.
Storage buffer
pH: 7.6 Preservative: 0.1% Sodium azide Constituents: PBS, 1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
Do Not Freeze

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Cytokeratin 18 (CK18) also known as Keratin 18 or KRT18 is a type I intermediate filament protein with a molecular weight of approximately 45 kDa. It plays a mechanical role in stabilizing epithelial cell structure and function. CK18 is expressed in single-layered epithelial tissues such as the liver intestine and pancreas. It partners with the type II keratin usually KRT8 to form a stable cytoskeletal network in these cells providing structural integrity and resilience.
Biological function summary

CK18 maintains cellular integrity and mediates resistance to mechanical and non-mechanical stresses in epithelial cells. It forms heterodimers with KRT8 participating in a complex network of filaments important for maintaining cell shape and stability. This organization plays a role in managing cell survival during stress and apoptosis helping regulate cellular functions and responses in tissues where it is expressed.

Pathways

Cytokeratin 18 is involved in the apoptosis and cellular stress response pathways. It interacts with proteins such as caspases during apoptosis facilitating cytoskeletal reorganization and cell fragmentation. CK18 in coordination with KRT8 also participates in signaling pathways that regulate cell cycle and apoptotic processes underlining its importance in cellular turnover and tissue homeostasis.

Elevated levels of CK18 fragments are often observed in cases of non-alcoholic steatohepatitis (NASH) and breast cancer. It serves as a biomarker for liver injury due to its abundance in hepatocytes and release upon cell death. In breast cancer alterations in CK18 expression can reflect disease progression where it interacts with other proteins such as vimentin indicating epithelial-to-mesenchymal transition a process that facilitates metastasis.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Involved in the uptake of thrombin-antithrombin complexes by hepatic cells (By similarity). When phosphorylated, plays a role in filament reorganization. Involved in the delivery of mutated CFTR to the plasma membrane. Together with KRT8, is involved in interleukin-6 (IL-6)-mediated barrier protection.
See full target information KRT18

Publications (9)

Recent publications for all applications. Explore the full list and refine your search

JCI insight 9: PubMed39352744

2024

Interpretable machine learning uncovers epithelial transcriptional rewiring and a role for Gelsolin in COPD.

Applications

Unspecified application

Species

Unspecified reactive species

Justin Sui,Hanxi Xiao,Ugonna Mbaekwe,Nai-Chun Ting,Kaley Murday,Qianjiang Hu,Alyssa D Gregory,Theodore S Kapellos,Ali Öender Yildirim,Melanie Königshoff,Yingze Zhang,Frank Sciurba,Jishnu Das,Corrine R Kliment

iScience 26:108246 PubMed38026152

2023

Homoporous polydimethylsiloxane membrane microfilter for ultrafast label-free isolation and recognition of circulating tumor cells in peripheral blood.

Applications

Unspecified application

Species

Unspecified reactive species

Peng Xie,Xiaoyue Yao,Zhenyu Chu,Yang Yang,Haifeng Li,Siyuan Tan,Haodong Tang,Jiahua Zhou,Wanqin Jin

Frontiers in medicine 9:1003914 PubMed36275794

2022

Establishment of a ccRCC patient-derived chick chorioallantoic membrane model for drug testing.

Applications

Unspecified application

Species

Unspecified reactive species

Martine Charbonneau,Kelly Harper,Karine Brochu-Gaudreau,Alexis Perreault,Patrick P McDonald,Nadia Ekindi-Ndongo,Claudio Jeldres,Claire M Dubois

Cancers 13: PubMed34831007

2021

miR-1227 Targets SEC23A to Regulate the Shedding of Large Extracellular Vesicles.

Applications

Unspecified application

Species

Unspecified reactive species

Andrew Chin,Javier Mariscal,Minhyung Kim,Giorgia Guerra,Blandine Victor,Chen Qian,Elisabetta Broseghini,Edwin Posadas,Michael R Freeman,Shivani Sharma,Paolo Gandellini,Nadia Zaffaroni,Sungyong You,Keith Syson Chan,Jlenia Guarnerio,Muller Fabbri,Dolores Di Vizio

Journal of extracellular vesicles 9:1764192 PubMed32944167

2020

Comprehensive palmitoyl-proteomic analysis identifies distinct protein signatures for large and small cancer-derived extracellular vesicles.

Applications

Unspecified application

Species

Unspecified reactive species

Javier Mariscal,Tatyana Vagner,Minhyung Kim,Bo Zhou,Andrew Chin,Mandana Zandian,Michael R Freeman,Sungyong You,Andries Zijlstra,Wei Yang,Dolores Di Vizio

Journal of extracellular vesicles 7:1505403 PubMed30108686

2018

Large extracellular vesicles carry most of the tumour DNA circulating in prostate cancer patient plasma.

Applications

Unspecified application

Species

Unspecified reactive species

Tatyana Vagner,Cristiana Spinelli,Valentina R Minciacchi,Leonora Balaj,Mandana Zandian,Andrew Conley,Andries Zijlstra,Michael R Freeman,Francesca Demichelis,Subhajyoti De,Edwin M Posadas,Hisashi Tanaka,Dolores Di Vizio

Molecular cancer therapeutics 14:2473-85 PubMed26269605

2015

CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Jingyu Xiang,Michelle A Hurchla,Francesca Fontana,Xinming Su,Sarah R Amend,Alison K Esser,Garry J Douglas,Chidananda Mudalagiriyappa,Kathryn E Luker,Timothy Pluard,Foluso O Ademuyiwa,Barbara Romagnoli,Gérald Tuffin,Eric Chevalier,Gary D Luker,Michael Bauer,Johann Zimmermann,Rebecca L Aft,Klaus Dembowsky,Katherine N Weilbaecher

Frontiers in physiology 6:87 PubMed25852573

2015

Chemical coding and chemosensory properties of cholinergic brush cells in the mouse gastrointestinal and biliary tract.

Applications

Unspecified application

Species

Unspecified reactive species

Burkhard Schütz,Innokentij Jurastow,Sandra Bader,Cornelia Ringer,Jakob von Engelhardt,Vladimir Chubanov,Thomas Gudermann,Martin Diener,Wolfgang Kummer,Gabriela Krasteva-Christ,Eberhard Weihe

Stem cells and development 23:44-55 PubMed23952781

2013

Human skin-derived stem cells as a novel cell source for in vitro hepatotoxicity screening of pharmaceuticals.

Applications

Unspecified application

Species

Unspecified reactive species

Robim M Rodrigues,Joery De Kock,Steven Branson,Mathieu Vinken,Kesavan Meganathan,Umesh Chaudhari,Agapios Sachinidis,Olivier Govaere,Tania Roskams,Veerle De Boe,Tamara Vanhaecke,Vera Rogiers
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com